Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 103

1.

Electrografting of a biodegradable layer as a primer adhesion coating onto a metallic stent: in vitro and in vivo evaluations.

Vergnol G, Renard E, Haroun F, Guerin P, Seron A, Bureau C, Loirand G, Langlois V.

J Mater Sci Mater Med. 2013 Dec;24(12):2729-39. doi: 10.1007/s10856-013-5015-1. Epub 2013 Aug 1.

PMID:
23904056
2.

Histopathological comparison of biodegradable polymer and permanent polymer based sirolimus eluting stents in a porcine model of coronary stent implantation.

Koppara T, Joner M, Bayer G, Steigerwald K, Diener T, Wittchow E.

Thromb Haemost. 2012 Jun;107(6):1161-71. doi: 10.1160/TH12-01-0043. Epub 2012 Apr 26.

PMID:
22535188
3.

Preparation of Polymeric Prodrug Paclitaxel-Poly(lactic acid)-b-Polyisobutylene and Its Application in Coatings of a Drug Eluting Stent.

Ren K, Zhang M, He J, Wu Y, Ni P.

ACS Appl Mater Interfaces. 2015 Jun 3;7(21):11263-71. doi: 10.1021/acsami.5b01410. Epub 2015 May 19.

PMID:
25955234
4.

Effects of interfacial layer wettability and thickness on the coating morphology and sirolimus release for drug-eluting stent.

Bedair TM, Yu SJ, Im SG, Park BJ, Joung YK, Han DK.

J Colloid Interface Sci. 2015 Dec 15;460:189-99. doi: 10.1016/j.jcis.2015.08.051. Epub 2015 Aug 24.

PMID:
26319336
5.

Development of a biodegradable sirolimus-eluting stent coated by ultrasonic atomizing spray.

Kim SJ, Park JG, Kim JH, Heo JS, Choi JW, Jang YS, Yoon J, Lee SJ, Kwon IK.

J Nanosci Nanotechnol. 2011 Jul;11(7):5689-97.

PMID:
22121592
6.

Drug-eluting stents.

García-García HM, Vaina S, Tsuchida K, Serruys PW.

Arch Cardiol Mex. 2006 Jul-Sep;76(3):297-319. Review.

PMID:
17091802
7.

BioMatrix Biolimus A9-eluting coronary stent: a next-generation drug-eluting stent for coronary artery disease.

Grube E, Buellesfeld L.

Expert Rev Med Devices. 2006 Nov;3(6):731-41. Review.

PMID:
17280537
8.

Preclinical evaluation of new indomethacin-eluting biodegradable urethral stent.

Kotsar A, Nieminen R, Isotalo T, Mikkonen J, Uurto I, Kellomäki M, Talja M, Moilanen E, Tammela TL.

J Endourol. 2012 Apr;26(4):387-92. doi: 10.1089/end.2011.0327. Epub 2012 Jan 4.

PMID:
22050507
9.

Effect of a novel peptide, WKYMVm- and sirolimus-coated stent on re-endothelialization and anti-restenosis.

Jang EJ, Bae IH, Park DS, Lee SY, Lim KS, Park JK, Shim JW, Sim DS, Jeong MH.

J Mater Sci Mater Med. 2015 Oct;26(10):251. doi: 10.1007/s10856-015-5585-1. Epub 2015 Oct 5.

PMID:
26438653
10.

Promoting endothelial recovery and reducing neointimal hyperplasia using sequential-like release of acetylsalicylic acid and paclitaxel-loaded biodegradable stents.

Lee CH, Yu CY, Chang SH, Hung KC, Liu SJ, Wang CJ, Hsu MY, Hsieh IC, Chen WJ, Ko YS, Wen MS.

Int J Nanomedicine. 2014 Aug 27;9:4117-33. doi: 10.2147/IJN.S67721. eCollection 2014.

11.

Surface characterization of poly(lactic acid)/everolimus and poly(ethylene vinyl alcohol)/everolimus stents.

Wu M, Kleiner L, Tang FW, Hossainy S, Davies MC, Roberts CJ.

Drug Deliv. 2010 Aug;17(6):376-84. doi: 10.3109/10717541003762847.

PMID:
20373889
12.

Evaluation of two polymeric blends (EVA/PLA and EVA/PEG) as coating film materials for paclitaxel-eluting stent application.

Liu X, Lei L, Hou JW, Tang MF, Guo SR, Wang ZM, Chen KM.

J Mater Sci Mater Med. 2011 Feb;22(2):327-37. doi: 10.1007/s10856-010-4213-3. Epub 2011 Jan 8.

PMID:
21221735
13.

Improved blood compatibility of rapamycin-eluting stent by incorporating curcumin.

Pan CJ, Tang JJ, Shao ZY, Wang J, Huang N.

Colloids Surf B Biointerfaces. 2007 Sep 1;59(1):105-11. Epub 2007 Apr 29.

PMID:
17540543
14.

6-Month Follow-Up of a Novel Biodegradable Drug-Eluting Stent Composed of Poly-L-Lactic Acid and Amorphous Calcium Phosphate Nanoparticles in Porcine Coronary Artery.

Xiao J, Feng G, Kang G, Lan Z, Liao T, Kislauskis E, Chen J, Xia J, Wang Z, Huo Z, Wang Q, Xi T, McCarthy S, Jiang X, Wu T, Laham R.

J Biomed Nanotechnol. 2015 Oct;11(10):1819-25.

PMID:
26502644
15.

Drug-eluting biodegradable poly-D/L-lactic acid vascular stents: an experimental pilot study.

Uurto I, Mikkonen J, Parkkinen J, Keski-Nisula L, Nevalainen T, Kellomäki M, Törmälä P, Salenius JP.

J Endovasc Ther. 2005 Jun;12(3):371-9.

PMID:
15943514
16.

Enhanced drug delivery capabilities from stents coated with absorbable polymer and crystalline drug.

Carlyle WC, McClain JB, Tzafriri AR, Bailey L, Zani BG, Markham PM, Stanley JR, Edelman ER.

J Control Release. 2012 Sep 28;162(3):561-7. doi: 10.1016/j.jconrel.2012.07.004. Epub 2012 Jul 16.

17.

Vascular response and mechanical integrity of the new biodegradable polymer coated sirolimus-eluting PROLIM stent implanted in porcine coronary arteries.

Milewski K, Gorycki B, Buszman PP, Jelonek M, Beaudry D, Lapointe JM, Guy LG, Abusamra M, Pająk J, Kinasz W, Wojakowski W, Leclerc G, Gil RJ, Buszman PE.

Kardiol Pol. 2012;70(7):703-11.

18.

Paclitaxel releasing films consisting of poly(vinyl alcohol)-graft-poly(lactide-co-glycolide) and their potential as biodegradable stent coatings.

Westedt U, Wittmar M, Hellwig M, Hanefeld P, Greiner A, Schaper AK, Kissel T.

J Control Release. 2006 Mar 10;111(1-2):235-46. Epub 2006 Feb 8.

PMID:
16466824
19.

Drug-eluting stent with improved durability and controllability properties, obtained via electrocoated adhesive promotion layer.

Levy Y, Tal N, Tzemach G, Weinberger J, Domb AJ, Mandler D.

J Biomed Mater Res B Appl Biomater. 2009 Nov;91(2):819-30. doi: 10.1002/jbm.b.31461.

PMID:
19582851
20.

Coating bioabsorption and chronic bare metal scaffolding versus fully bioabsorbable stent.

Waksman R, Pakala R.

EuroIntervention. 2009 Dec 15;5 Suppl F:F36-42. doi: 10.4244/EIJV5IFA6. Review.

PMID:
22100674

Supplemental Content

Support Center